Immuno Oncology Assays
SKU
MRR-43676CF42882
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 6.26 billion
2030
USD 16.93 billion
2024
USD 7.21 billion
CAGR
15.26%

Immuno Oncology Assays Market by Indication (Bladder Cancer, Colorectal Cancer, Lung Cancer), Product (Consumables, Software), Technology, Application - Global Forecast 2024-2030

[185 Pages Report] The Immuno Oncology Assays Market size was estimated at USD 6.26 billion in 2023 and expected to reach USD 7.21 billion in 2024, at a CAGR 15.26% to reach USD 16.93 billion by 2030.

Immuno Oncology Assays Market
To learn more about this report, request a free PDF copy
Immuno Oncology Assays Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Immuno Oncology Assays Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immuno Oncology Assays Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Immuno Oncology Assays Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, LLC, Charles River Laboratories International, Inc., ElsaLys Biotech S.A., Eurofins DiscoverX Products, LLC, HTG Molecular Diagnostics, Inc., Illumina, Inc., Merck KGaA, NanoString Technologies, Inc., NeoGenomics Laboratories, Inc., PerkinElmer, Inc., QIAGEN GmbH, Sartorius AG, Thermo Fisher Scientific, Inc., and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Immuno Oncology Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Bladder Cancer
    • Colorectal Cancer
    • Lung Cancer
    • Melanoma
  • Product
    • Consumables
    • Software
  • Technology
    • Flow Cytometry
    • Immunoassay
    • Next-Generation Sequencing
    • Polymerase Chain Reaction
  • Application
    • Clinical Diagnostics
    • Research

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Immuno Oncology Assays Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immuno Oncology Assays Market?
  3. What are the technology trends and regulatory frameworks in the Immuno Oncology Assays Market?
  4. What is the market share of the leading vendors in the Immuno Oncology Assays Market?
  5. Which modes and strategic moves are suitable for entering the Immuno Oncology Assays Market?

Table of Contents
  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Define: Research Objective
    2. Determine: Research Design
    3. Prepare: Research Instrument
    4. Collect: Data Source
    5. Analyze: Data Interpretation
    6. Formulate: Data Verification
    7. Publish: Research Report
    8. Repeat: Report Update
  3. Executive Summary
  4. Market Overview
  5. Market Insights
    1. Market Dynamics
      1. Drivers
        1. Growing incidences of cancer and adoption of targeted therapy over other treatment options
        2. Development of bioinformatic tools enhancing the drug development process
        3. Rise in healthcare expenditure and healthcare insurance
      2. Restraints
        1. Unfavorable regulatory and reimbursement scenario
      3. Opportunities
        1. Technological advancement and R&D for the treatment of cancer
        2. Emergence of companion diagnostics
      4. Challenges
        1. Lack of healthcare professions for device operation
    2. Market Segmentation Analysis
    3. Market Trend Analysis
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Immuno Oncology Assays Market, by Indication
    1. Introduction
    2. Bladder Cancer
    3. Colorectal Cancer
    4. Lung Cancer
    5. Melanoma
  7. Immuno Oncology Assays Market, by Product
    1. Introduction
    2. Consumables
    3. Software
  8. Immuno Oncology Assays Market, by Technology
    1. Introduction
    2. Flow Cytometry
    3. Immunoassay
    4. Next-Generation Sequencing
    5. Polymerase Chain Reaction
  9. Immuno Oncology Assays Market, by Application
    1. Introduction
    2. Clinical Diagnostics
    3. Research
  10. Americas Immuno Oncology Assays Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  11. Asia-Pacific Immuno Oncology Assays Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. Singapore
    10. South Korea
    11. Taiwan
    12. Thailand
    13. Vietnam
  12. Europe, Middle East & Africa Immuno Oncology Assays Market
    1. Introduction
    2. Denmark
    3. Egypt
    4. Finland
    5. France
    6. Germany
    7. Israel
    8. Italy
    9. Netherlands
    10. Nigeria
    11. Norway
    12. Poland
    13. Qatar
    14. Russia
    15. Saudi Arabia
    16. South Africa
    17. Spain
    18. Sweden
    19. Switzerland
    20. Turkey
    21. United Arab Emirates
    22. United Kingdom
  13. Competitive Landscape
    1. Market Share Analysis, 2023
    2. FPNV Positioning Matrix, 2023
    3. Competitive Scenario Analysis
  14. Competitive Portfolio
    1. Key Company Profiles
    2. Key Product Portfolio
  15. List of Figures [Total: 24]
    1. IMMUNO ONCOLOGY ASSAYS MARKET RESEARCH PROCESS
    2. IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2023 VS 2030
    3. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
    4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
    5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
    6. IMMUNO ONCOLOGY ASSAYS MARKET DYNAMICS
    7. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
    8. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    9. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
    10. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
    11. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
    12. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
    13. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
    14. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
    15. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    16. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    17. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
    18. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
    19. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    20. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    21. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
    22. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
    23. IMMUNO ONCOLOGY ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
    24. IMMUNO ONCOLOGY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
  16. List of Tables [Total: 376]
    1. IMMUNO ONCOLOGY ASSAYS MARKET SEGMENTATION & COVERAGE
    2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    3. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2018-2023 (USD MILLION)
    4. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, 2024-2030 (USD MILLION)
    5. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
    6. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
    7. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    8. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    9. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLADDER CANCER, BY REGION, 2018-2023 (USD MILLION)
    10. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY BLADDER CANCER, BY REGION, 2024-2030 (USD MILLION)
    11. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2023 (USD MILLION)
    12. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2024-2030 (USD MILLION)
    13. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
    14. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
    15. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY REGION, 2018-2023 (USD MILLION)
    16. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY MELANOMA, BY REGION, 2024-2030 (USD MILLION)
    17. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    18. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    19. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
    20. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
    21. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
    22. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
    23. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    24. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    25. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2023 (USD MILLION)
    26. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2024-2030 (USD MILLION)
    27. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2023 (USD MILLION)
    28. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2024-2030 (USD MILLION)
    29. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2023 (USD MILLION)
    30. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2024-2030 (USD MILLION)
    31. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2023 (USD MILLION)
    32. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2024-2030 (USD MILLION)
    33. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    34. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    35. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
    36. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
    37. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2023 (USD MILLION)
    38. GLOBAL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY RESEARCH, BY REGION, 2024-2030 (USD MILLION)
    39. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    40. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    41. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    42. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    43. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    44. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    45. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    46. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    47. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    48. AMERICAS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    49. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    50. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    51. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    52. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    53. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    54. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    55. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    56. ARGENTINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    57. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    58. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    59. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    60. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    61. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    62. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    63. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    64. BRAZIL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    65. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    66. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    67. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    68. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    69. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    70. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    71. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    72. CANADA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    73. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    74. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    75. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    76. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    77. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    78. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    79. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    80. MEXICO IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    81. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    82. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    83. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    84. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    85. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    86. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    87. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    88. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    89. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
    90. UNITED STATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
    91. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    92. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    93. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    94. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    95. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    96. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    97. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    98. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    99. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    100. ASIA-PACIFIC IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    101. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    102. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    103. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    104. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    105. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    106. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    107. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    108. AUSTRALIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    109. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    110. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    111. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    112. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    113. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    114. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    115. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    116. CHINA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    117. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    118. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    119. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    120. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    121. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    122. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    123. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    124. INDIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    125. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    126. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    127. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    128. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    129. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    130. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    131. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    132. INDONESIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    133. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    134. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    135. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    136. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    137. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    138. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    139. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    140. JAPAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    141. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    142. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    143. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    144. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    145. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    146. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    147. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    148. MALAYSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    149. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    150. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    151. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    152. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    153. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    154. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    155. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    156. PHILIPPINES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    157. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    158. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    159. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    160. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    161. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    162. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    163. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    164. SINGAPORE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    165. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    166. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    167. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    168. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    169. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    170. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    171. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    172. SOUTH KOREA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    173. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    174. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    175. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    176. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    177. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    178. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    179. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    180. TAIWAN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    181. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    182. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    183. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    184. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    185. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    186. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    187. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    188. THAILAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    189. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    190. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    191. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    192. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    193. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    194. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    195. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    196. VIETNAM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    197. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    198. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    199. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    200. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    201. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    202. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    203. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    204. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    205. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
    206. EUROPE, MIDDLE EAST & AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
    207. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    208. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    209. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    210. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    211. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    212. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    213. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    214. DENMARK IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    215. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    216. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    217. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    218. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    219. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    220. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    221. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    222. EGYPT IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    223. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    224. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    225. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    226. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    227. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    228. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    229. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    230. FINLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    231. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    232. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    233. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    234. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    235. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    236. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    237. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    238. FRANCE IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    239. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    240. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    241. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    242. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    243. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    244. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    245. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    246. GERMANY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    247. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    248. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    249. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    250. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    251. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    252. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    253. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    254. ISRAEL IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    255. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    256. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    257. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    258. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    259. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    260. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    261. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    262. ITALY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    263. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    264. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    265. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    266. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    267. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    268. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    269. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    270. NETHERLANDS IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    271. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    272. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    273. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    274. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    275. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    276. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    277. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    278. NIGERIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    279. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    280. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    281. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    282. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    283. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    284. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    285. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    286. NORWAY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    287. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    288. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    289. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    290. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    291. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    292. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    293. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    294. POLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    295. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    296. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    297. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    298. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    299. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    300. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    301. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    302. QATAR IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    303. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    304. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    305. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    306. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    307. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    308. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    309. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    310. RUSSIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    311. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    312. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    313. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    314. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    315. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    316. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    317. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    318. SAUDI ARABIA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    319. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    320. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    321. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    322. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    323. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    324. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    325. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    326. SOUTH AFRICA IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    327. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    328. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    329. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    330. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    331. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    332. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    333. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    334. SPAIN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    335. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    336. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    337. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    338. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    339. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    340. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    341. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    342. SWEDEN IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    343. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    344. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    345. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    346. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    347. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    348. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    349. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    350. SWITZERLAND IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    351. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    352. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    353. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    354. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    355. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    356. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    357. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    358. TURKEY IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    359. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    360. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    361. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    362. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    363. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    364. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    365. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    366. UNITED ARAB EMIRATES IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    367. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
    368. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
    369. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
    370. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
    371. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
    372. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
    373. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
    374. UNITED KINGDOM IMMUNO ONCOLOGY ASSAYS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
    375. IMMUNO ONCOLOGY ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
    376. IMMUNO ONCOLOGY ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023
  17. List of Companies Mentioned [Total: 16]
    1. Agilent Technologies, Inc.
    2. Bio-Rad Laboratories, Inc.
    3. BioAgilytix Labs, LLC
    4. Charles River Laboratories International, Inc.
    5. ElsaLys Biotech S.A.
    6. Eurofins DiscoverX Products, LLC
    7. HTG Molecular Diagnostics, Inc.
    8. Illumina, Inc.
    9. Merck KGaA
    10. NanoString Technologies, Inc.
    11. NeoGenomics Laboratories, Inc.
    12. PerkinElmer, Inc.
    13. QIAGEN GmbH
    14. Sartorius AG
    15. Thermo Fisher Scientific, Inc.
    16. Twist Bioscience Corporation
Frequently Asked Questions
  1. How big is the Immuno Oncology Assays Market?
    Ans. The Global Immuno Oncology Assays Market size was estimated at USD 6.26 billion in 2023 and expected to reach USD 7.21 billion in 2024.
  2. What is the Immuno Oncology Assays Market growth?
    Ans. The Global Immuno Oncology Assays Market to grow USD 16.93 billion by 2030, at a CAGR of 15.26%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.